ElizabethMoreBrettonMDCPI

Family Medicine • Albuquerque, NM

Medical Director

Join to view full profile

Dr. Bretton is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bretton's full profile

Already have an account?

Office
717 Encino Place NE
Suite 24
Albuquerque, NM 87102
Phone+1 505-224-7400

Fax+1 505-224-7404

Education & Training

Baylor College of MedicineResidency, Family Medicine, 1985 - 1987
University of MichiganResidency, Neurology, 1983 - 1984
Baylor College of MedicineInternship, Internal Medicine, 1982 - 1983
Baylor College of MedicineClass of 1982

Certifications & Licensure

NM State Medical License 1993 - 2024

Clinical Trials

The Plecanatide Chronic Idiopathic Constipation (CIC) Study Start of enrollment: 2011 Oct 01
Completed
Phase 2, Phase 3
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis Start of enrollment: 2013 Jun 27
Completed
Phase 3
Phase IIB Dose Ranging Study in Subjects With Moderate to Severe Rheumatoid Arthritis Start of enrollment: 2012 Jun 01
Completed
Phase 2
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus Start of enrollment: 2014 Jan 01
Terminated
Phase 3
12-Week Study of Plecanatide for CIC (The National CIC3 Study) Start of enrollment: 2014 Apr 01
Completed
Phase 3
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache Start of enrollment: 2014 Jul 07
Completed
Phase 2
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM Start of enrollment: 2015 Sep 01
Completed
Phase 2
Join now to see all